Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

LPHN2 (latrophilin 2)

Identity

Other namesLPHH1
LEC1
KIAA0786
HGNC (Hugo) LPHN2
LocusID (NCBI) 23266
Location 1p31.1
Location_base_pair Starts at 82266082 and ends at 82458107 bp from pter ( according to hg19-Feb_2009)  [Mapping]
Local_order --ELTD1---LPHH1----FLJ23033----PRKACB--
 
  Probe(s) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics

DNA/RNA

 
  Representation of the genomic structure of LPHH1. Black blocks represent core exons which are present in the majority of gene transcripts. The yellow blocks represent alternatively spliced coding exons which may be incorporated variably in transcripts derived from different cell types/tissues or as a consequence of differing cellular states. The red boxes represent the presence of multiple, in some cases tissue-specific, leader exons that have been identified for this gene, an observation consistent with the existence of multiple dispersed promoter elements. The most variably spliced region of the coding sequence was the carboxy-terminal domain D.
Description LPHH1 consists of 19 commonly used coding exons. A further seven exons have been identified which may be alternatively spliced into the core backbone with variable frequencies and tissue specificities. At least a number of these additional exons are highly conserved in mammalian species. The core exons (ATG, exon 1 to stop, exon 19) span a region of about 154kb. However, the 5'end of the gene is not precisely defined with transcripts in different tissues apparently initiating from specific locations over an extensive region. The most distant leader exon identified (foetal lung) lies approximately 390kb from exon 1 which makes the total size of the gene at least 550kb.
Transcription Expression has been observed by RT-PCR in all normal tissues and lines tested with the clear exception of lymphocytes and lymphoblastoid cells. Strongest expression was observed in foetal lung, normal adult lung and thyroid. Alternative splicing to some degree in at least one domain (minimally the carboxy-terminal domain D) was seen in each tissue and line examined with human brain showing a characteristic pattern and additional variability in the other three coding sequence domains.
Pseudogene No known pseudogene.

Protein

 
  Alternative splicing in domain D dramatically alters the structure of the carboxy-terminus of the encoded protein, latrophilin 2. Variable splicing in this region occurs in all tissues and cell lines tested.
Description LPHH1 encodes a putative seven-span transmembrane receptor with atypically large extra membrane N (predicted to be extra-cellular) and C termini. In addition to the seven hydrophobic membrane spanning domains, a putative lectin-like region is present near the N-terminus.
Expression Protein likely to be ubiquitously expressed in adherent cells but that has not so far been confirmed. Human brain-specific alternative splices alter the structure of the extra-membrane, intra-cellular loop between TM domains 5 and 6, a region thought to be critical for G-protein/receptor interactions.
Localisation Likely to be plasma membrane.
Function Likely role in coupling cell adhesion to cell signalling.
Homology Latrophilin 2 is part of a small sub-family of 7TMs which includes latrophilins 1 and 3. Latrophilin 1 is the receptor for Black Widow spider toxin: -latrotoxin.

Mutations

Note None reported.

Implicated in

Entity Breast carcinoma
Note Analysis of breast cancer cell lines has demonstrated dramatic differences in transcript levels between certain lines. In one case, strong expression was allelically imbalanced.
  
Entity Lung carcinoma
Note strong expression in normal lung was reduced in 55% (35/64) of matched primary non-small cell lung carcinomas (NSCLC). Over-representation was not scored in any tumour, nor in any lung cancer cell line tested and transcript was undetectable by RT-PCR in one line (1/15) and very low in a further two. Loss of heterozygosity was scored in 8/16 informative NSCLC lesions. Primary and SCLC lines showed a characteristic pattern of alternative splicing.
  

External links

Nomenclature
HGNC (Hugo)LPHN2   18582
Entrez_Gene (NCBI)LPHN2  23266  latrophilin 2
Cards
AtlasLPHH1ID313
GeneCards (Weizmann)LPHN2
Ensembl (Hinxton)ENSG00000117114 [Gene_View]  chr1:82266082-82458107 [Contig_View]  LPHN2 [Vega]
AceView (NCBI)LPHN2
Genatlas (Paris)LPHN2
euGene (Indiana)23266
SOURCE (Stanford)NM_012302
Genomic and cartography
GoldenPath (UCSC)LPHN2  -  1p31.1   chr1:82266082-82458107 +  1p31.1   [Description]    (hg19-Feb_2009)
EnsemblLPHN2 - 1p31.1 [CytoView]
Mapping of homologs : NCBILPHN2 [Mapview]
OMIM607018   
Gene and transcription
Genbank (Entrez)AB018329 AF104266 AF104938 AF104939 AJ131581
RefSeq transcript (SRS)NM_012302
RefSeq transcript (Entrez)NM_012302
RefSeq genomic (SRS)AC_000133 NC_000001 NT_032977 NW_001838579
RefSeq genomic (Entrez)AC_000133 NC_000001 NT_032977 NW_001838579
Consensus coding sequences : CCDS (NCBI)LPHN2
Cluster EST : UnigeneHs.649282 [ SRS ] Hs.649282 [ NCBI ]
Alternative Splicing : Fast-db (Paris)16655
Alternative Splicing GalleryENSG00000117114
Gene ExpressionLPHN2 [ NCBI-GEO ]   LPHN2 [ EBI - ARRAY_EXPRESS ]
Protein : pattern, domain, 3D structure
UniProt/SwissProtO95490 (SRS) O95490 (Uniprot)
With graphics : InterProO95490
Splice isoforms : SwissVarO95490(Swissvar)
Domaine pattern : Prosite (SRS)G_PROTEIN_RECEP_F2_1 (PS00649)    G_PROTEIN_RECEP_F2_2 (PS00650)    G_PROTEIN_RECEP_F2_3 (PS50227)    G_PROTEIN_RECEP_F2_4 (PS50261)    GPS (PS50221)    OLF (PS51132)    SUEL_LECTIN (PS50228)   
Domaine pattern : Prosite (Expaxy)G_PROTEIN_RECEP_F2_1 (PS00649)    G_PROTEIN_RECEP_F2_2 (PS00650)    G_PROTEIN_RECEP_F2_3 (PS50227)    G_PROTEIN_RECEP_F2_4 (PS50261)    GPS (PS50221)    OLF (PS51132)    SUEL_LECTIN (PS50228)   
Domains : Interpro (SRS)DUF3497    GPCR_2-like    GPCR_2_extracellular_dom    GPCR_2_latrophilin    GPCR_2_latrophilin_rcpt_C    GPCR_2_secretin-like    GPCR_2_secretin-like_CS    GPS_dom    Lectin_gal-bd_dom    Olfac-like   
Domains : Interpro (EBI)DUF3497    GPCR_2-like    GPCR_2_extracellular_dom    GPCR_2_latrophilin    GPCR_2_latrophilin_rcpt_C    GPCR_2_secretin-like    GPCR_2_secretin-like_CS    GPS_dom    Lectin_gal-bd_dom    Olfac-like   
Related proteins : CluSTrO95490
Domain families : Pfam (SRS)7tm_2 (PF00002)    DUF3497 (PF12003)    Gal_Lectin (PF02140)    GPS (PF01825)    HRM (PF02793)    Latrophilin (PF02354)    OLF (PF02191)   
Domain families : Pfam (Sanger)7tm_2 (PF00002)    DUF3497 (PF12003)    Gal_Lectin (PF02140)    GPS (PF01825)    HRM (PF02793)    Latrophilin (PF02354)    OLF (PF02191)   
Domain families : Pfam (NCBI)pfam00002    pfam12003    pfam02140    pfam01825    pfam02793    pfam02354    pfam02191   
Domain families : Smart (EMBL)GPS (SM00303)  HormR (SM00008)  OLF (SM00284)  
Blocks (Seattle)O95490
Human Protein AtlasENSG00000117114
HPRD06116
IPIIPI00410232   IPI00017562   IPI00410234   IPI00164345   IPI00902461   IPI00815751   IPI00645074   IPI00816469   IPI00644480   IPI00646434   IPI00479140   IPI00641868   IPI00642406   IPI00642961   
Protein Interaction databases
DIP (DOE-UCLA)O95490
IntAct (EBI)O95490
FunCoupENSG00000117114
REACTOMELPHN2
BioGRIDLPHN2
InParanoidO95490
Interologous Interaction database O95490
Polymorphism : SNP, mutations, diseases
SNP Single Nucleotide Polymorphism (NCBI)LPHN2
SNP (GeneSNP Utah)LPHN2
SNP : HGBaseLPHN2
Genetic variants : HAPMAPLPHN2
Somatic Mutations in Cancer : COSMICLPHN2 
CONAN: Copy Number AnalysisLPHN2 
Mutations and Diseases : HGMDLPHN2
OMIM607018   
GENETests607018   
Disease Genetic AssociationLPHN2
Huge Navigator LPHN2 [HugePedia]  LPHN2 [HugeCancerGEM]
Genomic VariantsLPHN2
snp3D : Map Gene to Disease23266
General knowledge
Homologs : HomoloGeneLPHN2
Homology/Alignments : Family Browser (UCSC)LPHN2
Phylogenetic Trees/Animal Genes : TreeFamLPHN2
Chemical/Protein Interactions : CTD23266
Chemical/Pharm GKB GenePA38589
Clinical trialLPHN2
Cancer Resource (Charite)ENSG00000117114
Ontology : AmiGOsignal transducer activity  receptor activity  G-protein coupled receptor activity  sugar binding  plasma membrane  G-protein coupled receptor signaling pathway  neuropeptide signaling pathway  integral to membrane  latrotoxin receptor activity  
Ontology : EGO-EBIsignal transducer activity  receptor activity  G-protein coupled receptor activity  sugar binding  plasma membrane  G-protein coupled receptor signaling pathway  neuropeptide signaling pathway  integral to membrane  latrotoxin receptor activity  
Other databases
Probes
Probes : ImagenesLPHN2 Related clones (RZPD - Berlin)
Litterature
PubMed14 Pubmed reference(s) in Entrez
PubGeneLPHN2
iHOPLPHN2

Bibliography

Genomic structure and expression profile of LPHH1, a 7TM gene variably expressed in breast cancer cell lines.
White GR, Varley JM, Heighway J
Biochimica et biophysica acta. 2000 ; 1491 (1-3) : 75-92.
PMID 10760572
 
A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.
Hayflick JS
Journal of receptor and signal transduction research. 2000 ; 20 (2-3) : 119-131.
PMID 10994649
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written11-2003Jim Heighway
Roy Castle International Centre for Lung Cancer Research, Liverpool, UK

Citation

This paper should be referenced as such :
Heighway J . LPHN2 (latrophilin 2). Atlas Genet Cytogenet Oncol Haematol. November 2003 .
URL : http://AtlasGeneticsOncology.org/Genes/LPHH1ID313.html

This paper is referenced by INIST as such :
http://documents.irevues.inist.fr/bitstream/2042/38040/1/11-2003-LPHH1ID313.pdf   [ Bibliographic record ]

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Apr 28 15:10:13 CEST 2012

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.